Status:
COMPLETED
Hospital-acquired Pneumonia Prevention: Intervention, Evaluation & Research
Lead Sponsor:
Orlando Health, Inc.
Collaborating Sponsors:
Medline Industries
Conditions:
Healthcare-Associated Pneumonia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine the effectiveness of a universal, standardized oral care protocol on prevention of non-ventilated hospital-acquired pneumonia (NV-HAP) in the acute care setti...
Detailed Description
Prior to the study, the research team will have a lead-in period where education will be provided to the interventional groups and demonstration of desired oral care practices for patients (September ...
Eligibility Criteria
Inclusion
- • in-patient adults (18 and older) in control (one medical/one surgical) and interventional (one medical/one surgical) study units in whom oral care is not contraindicated
Exclusion
- patients who are on mechanical ventilation, intubated orally, or with tracheostomy
- patients who have contraindications for oral care.
Key Trial Info
Start Date :
October 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2020
Estimated Enrollment :
8709 Patients enrolled
Trial Details
Trial ID
NCT04915898
Start Date
October 1 2018
End Date
April 30 2020
Last Update
February 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Orlando Health
Orlando, Florida, United States, 32806